Volume 23, Number 10—October 2017
Research
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
Table 1
Serial no. | PID types | No. cases | M/F ratio | Age range, mo |
---|---|---|---|---|
1 | Hemophagocytic lymphohistiocytosis | 11 | 10/1 | 4–96 |
2 | X-linked agammaglobulinemia | 7 | 7/0 | 27–216 |
3 | Chronic granulomatous disease | 4 | 3/1 | 7–60 |
4 | Severe combined immunodeficiency | 4 | 4/0 | 4–48 |
5 | Common variable immunodeficiency | 3 | 2/1 | 84–120 |
6 | Chédiak–Higashi syndrome | 3 | 1/2 | 26–86 |
7 | Hypogammaglobulinemia | 2 | 1/1 | 96–108 |
8 | IgG subclass deficiency | 2 | 0/2 | 84–114 |
9 | Hyper-IgM syndrome | 2 | 2/0 | 17–59 |
10 | Autoimmune lymphoproliferative syndrome | 1 | 0/1 | 15 |
11 | B cell expansion with NF-κB and T cell anergy | 1 | 1/0 | 18 |
12 | Hyper-IgE syndrome | 1 | 1/0 | 42 |
13 |
Interleukin 12 receptor β1 defect |
1 |
1/0 |
156 |
Total | 42 | 33/9 | 4–216 |
*PID, primary immunodeficiency
Page created: September 18, 2017
Page updated: September 18, 2017
Page reviewed: September 18, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.